SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-21-020250
Filing Date
2021-04-06
Accepted
2021-04-05 20:36:47
Documents
13

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 3 TO FORM S-1 ea138913-posam_adialpharma.htm POS AM 1480379
2 CONSENT OF FRIEDMAN LLP ea138913-ex23_1adialpharma.htm EX-23.1 2597
3 GRAPHIC image_001.jpg GRAPHIC 27640
4 GRAPHIC image_002.jpg GRAPHIC 97130
5 GRAPHIC image_003.jpg GRAPHIC 37065
6 GRAPHIC image_004.jpg GRAPHIC 39361
7 GRAPHIC image_005.jpg GRAPHIC 97130
8 GRAPHIC image_006.jpg GRAPHIC 65081
9 GRAPHIC image_007.jpg GRAPHIC 15563
10 GRAPHIC image_008.jpg GRAPHIC 16568
11 GRAPHIC image_009.jpg GRAPHIC 16501
12 GRAPHIC image_010.jpg GRAPHIC 19524
13 GRAPHIC image_011.jpg GRAPHIC 6056
  Complete submission text file 0001213900-21-020250.txt   2088256
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-220368 | Film No.: 21807752
SIC: 2834 Pharmaceutical Preparations